SCHEMBL25580935

SCHEMBL25580935

c1ccc(-c2ccccc2-c2c(-c3ccccc3)cccc2-c2cccc(N(c3ccc4ccccc4c3)c3ccc4c(c3)oc3ccccc34)c2)cc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AHR P35869 2/20 0.33
▸ ALDH1A1 P00352 4/20 0.33
▸ MAPT P10636 3/20 0.33
▸ CYP1A1 P04798 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP1B1 Q16678 1/20 0.33
▸ ALOX5 P09917 1/20 0.33
▸ MEN1 O00255 4/20 0.33
▸ KMT2A Q03164 4/20 0.33
▸ KDM4E B2RXH2 2/20 0.33
▸ HPGD P15428 2/20 0.33
▸ THRB P10828 1/20 0.32
▸ RECQL P46063 1/20 0.32
▸ BLM P54132 1/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32
▸ DUSP3 P51452 1/20 0.32
▸ RAB9A P51151 2/20 0.32
▸ MAOB P27338 1/20 0.32
▸ GPR84 Q9NQS5 1/20 0.31
▸ PRKDC P78527 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25581019 0.96 HCRTR1 (0.35) AHRALDH1A1MAPTCYP1A1CYP1A2
SCHEMBL25580653 0.94 AHR (0.34) AHRALDH1A1MAPTALOX5MEN1
SCHEMBL25580888 0.94 HCRTR1 (0.34) AHRALDH1A1MAPTCYP1A1CYP1A2
SCHEMBL25580749 0.94 HCRTR1 (0.35) AHRALDH1A1MAPTCYP1A1CYP1A2
SCHEMBL25580930 0.93 ALDH1A1 (0.34) AHRALDH1A1MAPTCYP1A1CYP1A2
SCHEMBL25580790 0.92 MCL1 (0.36) AHRALDH1A1MAPTCYP1A1CYP1A2
SCHEMBL25580978 0.92 AHR (0.37) AHRALDH1A1MAPTCYP1B1ALOX5
SCHEMBL25581004 0.90 MCL1 (0.37) AHRALDH1A1MAPTCYP1A1CYP1A2
SCHEMBL25580601 0.90 HCRTR1 (0.34) AHRALDH1A1MAPTCYP1A1CYP1B1
SCHEMBL25580814 0.90 ALOX5 (0.37) AHRALDH1A1MAPTCYP1B1ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230180597-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-08 — — US disclosed
US-20230180597-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230180597-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE ESR1, L1CAM, ESR2 AHR 2882/4885ALDH1A1 449/4885MAPT 2089/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback